Align Tech Shows Strong Start to 2024 with Smart Moves

The company behind popular teeth-straightening tech just posted better-than-expected earnings for the first three months of the year. While some worry about slow patient visits in dentistry, this business still managed to beat profit and revenue predictions. It also plans to spend $200 million buying back its own shares, a move that usually makes investors feel good about the company’s future. Not everything is smooth sailing though. The war in the Middle East has caused minor disruptions in patient traffic and treatment sign-ups in that area. Still, company leaders say the impact is small and won’t change their long-term plans. They expect sales to stay strong in the next quarter, though not quite as high as some analysts thought they would be.

For the full year, the company expects sales to grow by 3% to 4%. That might sound slow, but it’s steady progress. Their most popular product, Clear Aligner, should keep growing at a similar pace. The company’s profits also came in higher than expected, showing that demand for their tech is still strong. Dentistry as a whole is still recovering from uneven patient visits last year. Some experts think things might stabilize by 2026, but no one is fully confident yet. Until then, businesses in the field have to keep adapting to changes in how people use dental services.

Actions